Evidence of PAX5 involvement in lymphomas paints it mainly as secondary player in pathogenic processes; however, its genetic alterations could be implicated in the development and progression of diffused large B-cell lymphoma (DLBCL), Anaplastic Large Cell Lymphoma (ALCL), and Mantle cell lymphoma (MCL). The gene discussed is PAX5; the disease is anaplastic large cell lymphoma.